Quest Diagnostics: Q1 Earnings Snapshot
8 Articles
8 Articles
'Safe Haven' Stock Quest Diagnostics Bounds Off 50-Day Line On Its Solid Report
Quest Diagnostics stock remains a "safe haven," an analyst said Tuesday after the company topped first-quarter expectations. The post 'Safe Haven' Stock Quest Diagnostics Bounds Off 50-Day Line On Its Solid Report appeared first on Investor's Business Daily.
Quest beats quarterly profit estimates on strong demand for diagnostic tests
(Reuters) -Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests. Demand for diagnostic checkups has grown in recent quarters as more people, especially older Americans, have sought non-urgent surgeries they had delayed. Diagnostic service providers such as Quest and Labcorp have also benefited from deals to manage hospital labs as they seek market s…
Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025
First quarter revenues of $2.65 billion, up 12.1% from 2024First quarter reported diluted earnings per share ("EPS") of $1.94, up 12.8% from 2024; and adjusted diluted EPS of $2.21, up 8.3% from 2024Full year 2025 reported diluted EPS now expected…
Quest Diagnostics (DGX) Stock Analysis: Unpacking the 5.32% Potential Upside for Investors
Quest Diagnostics Incorporated (NYSE: DGX) stands at the forefront of the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $19.35 billion, the company holds a significant position in the U.S. market, providing a wide range of diagnostic testing services. As a key player in healthcare, Quest Diagnostics offers an array of services, from routine clinical tests to advanced diagnostic inform…
Coverage Details
Bias Distribution
- 86% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage